Literature DB >> 31167162

Compound heterozygous mutations in the luteinizing hormone receptor signal peptide causing 46,XY disorder of sex development.

Iulia Potorac1, Ashutosh Trehan2,3, Kamila Szymańska4, Julie Fudvoye5, Albert Thiry6, Ilpo Huhtaniemi2,7, Adrian F Daly1, Albert Beckers1, Anne-Simone Parent5, Adolfo Rivero-Müller2,4,8.   

Abstract

Testosterone production by the fetal testis depends on a functional relationship between hCG and the LH/chorionic gonadotropin receptor (LHCGR). Failure of the receptor to correctly respond to its ligand leads to impaired sexual differentiation in males. A phenotypically female patient with pubertal delay had a 46,XY karyotype and was diagnosed with 46,XY disorder of sex development (DSD). Novel compound heterozygous LHCGR mutations were found in the signal peptide: a duplication p.L10_Q17dup of maternal origin, and a deletion (p.K12_L15del) and a p.L16Q missense mutation of paternal origin. cAMP production was very low for both the deletion and duplication mutations and was halved for the missense mutant. The duplication and missense mutations were both expressed intracellularly, but at very low levels at the cell membrane; they were most likely retained in the endoplasmic reticulum. The deletion mutant had a very limited intracellular expression, indicating impaired biosynthesis. There was reduced expression of all three mutants, which was most marked for the deletion mutation. There was also decreased protein expression of all three mutant receptors. In the deletion mutation, the presence of a lower-molecular-weight band corresponding to LHCGR monomer, probably due to lack of glycosylation, and a lack of bands corresponding to dimers/oligomers suggests absent ER entry. This novel case of 46,XY DSD illustrates how different LHCGR signal peptide mutations led to complete receptor inactivation by separate mechanisms. The study underlines the importance of specific regions of signal peptides and expands the spectrum of LHCGR mutations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31167162     DOI: 10.1530/EJE-19-0170

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  1 in total

1.  Activation of the PDGF β Receptor by a Persistent Artificial Signal Peptide.

Authors:  Lisa M Petti; Benjamin N Koleske; Daniel DiMaio
Journal:  J Mol Biol       Date:  2021-08-30       Impact factor: 6.151

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.